Cargando…
Pyoderma gangrenosum–like ulceration of the lower extremity secondary to sunitinib therapy: a case report
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor used for the treatment of multiple different types of malignancies. Serious grade 3–4 adverse events occur in <10% of the patient population and usually improve with dose reduction. One of the more rarely reported side effects of su...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024264/ https://www.ncbi.nlm.nih.gov/pubmed/29977559 http://dx.doi.org/10.1177/2050313X18783048 |